Precision Care and Health Disparities in Prostate Cancer

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor, Department of Urology, Northwestern Medicine - Feinberg School of Medicine; Affiliate Member of Center for Global Health and Center for Community Health
    BIOGRAPHY

Abstract

Data suggests that genetics comprises 42-58% of the prostate cancer risk. GWAS has found about 43% of the risk SNPs in Blacks and European Americans. Most of the SNPs that have been discovered are not associated with aggressive prostate cancer but are more common in men of African ancestry. The genetic variants account for the increased incidence of prostate cancer in Blacks and I posit that environment and namely social determinants of health account for the mortality disparity. We found that the rates of latent prostate cancer are 4-6 times lower in men of West African ancestry in Africa relative to both Black and White Americans. Further, I argue that the American environment itself accounts for the excess prostate cancer mortality seen in both White and Black Americans relative to Nigerian and other West African men. 

Learning Objectives:

1.    Identify the degree of the incidence disparity for Blacks.

2.    Identify the degree of the mortality disparity for Blacks.

3.    Discuss the degree to which the genetic SNPs are associated with younger age and increased risk of overall cancer.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
AUG 24, 2021 11:00 AM PDT
C.E. CREDITS
AUG 24, 2021 11:00 AM PDT
Date: August 24, 2021 Time: 11:00am (PDT), 1:00pm (EDT) Electron-based dissociation mechanisms have shown great promise for advanced characterization of biomolecules. However, routine adopti...
Loading Comments...
Show Resources